Polynovo Ltd logo

Polynovo Ltd

ASX:PNV (Australia)  
A$ 2.01 (0%) May 2
670.00
P/B:
20.10
Market Cap:
A$ 1.39B ($ 905.86M)
Enterprise V:
A$ 1.36B ($ 886.08M)
Volume:
2.05M
Avg Vol (2M):
1.88M
Also Trade In:
Volume:
2.05M
Avg Vol (2M):
1.88M

Business Description

Description
Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.
Name Current Vs Industry Vs History
Cash-To-Debt 2.98
Equity-to-Asset 0.71
Debt-to-Equity 0.22
Debt-to-EBITDA 6.83
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 29.67
Distress
Grey
Safe
Beneish M-Score -1.68
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 42.04
9-Day RSI 42.45
14-Day RSI 43.59
6-1 Month Momentum % 71.2
12-1 Month Momentum % 32.51

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.01
Quick Ratio 4.52
Cash Ratio 3.25
Days Inventory 354.69
Days Sales Outstanding 56.36
Days Payable 503.16

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.4
Shareholder Yield % -0.33

Financials (Next Earnings Date:2024-05-31 Est.)

ASX:PNV's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Polynovo Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 83.024
EPS (TTM) (A$) 0.003
Beta 1.79
Volatility % 44.73
14-Day RSI 43.59
14-Day ATR (A$) 0.079162
20-Day SMA (A$) 2.09
12-1 Month Momentum % 32.51
52-Week Range (A$) 1.095 - 2.52
Shares Outstanding (Mil) 690.23

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Polynovo Ltd Filings

Filing Date Document Date Form
No Filing Data

Polynovo Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Polynovo Ltd Frequently Asked Questions

What is Polynovo Ltd(ASX:PNV)'s stock price today?
The current price of ASX:PNV is A$2.01. The 52 week high of ASX:PNV is A$2.52 and 52 week low is A$1.10.
When is next earnings date of Polynovo Ltd(ASX:PNV)?
The next earnings date of Polynovo Ltd(ASX:PNV) is 2024-05-31 Est..
Does Polynovo Ltd(ASX:PNV) pay dividends? If so, how much?
Polynovo Ltd(ASX:PNV) does not pay dividend.

Press Release

Subject Date
No Press Release